Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2005
09/07/2005CN1663575A Chinese medicinal composition for treating rheumatic and rheumatoid arthritis
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/07/2005CN1217926C Novel vitamin D analogues
09/07/2005CN1217922C 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
09/07/2005CN1217687C Chinese herbal medicine for treating smelly feet and its preparing method
09/07/2005CN1217681C Externally applied paste for treating fracture and injured tendons and its preparing method
09/07/2005CN1217678C Chinese medicine for treating necrosis of femoral head
09/07/2005CN1217664C Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength
09/06/2005US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
09/06/2005US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/06/2005US6939868 Anticancer agents; skin disorders; bone disorders
09/06/2005US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds
09/06/2005US6939571 Process of making an osteopathy solution
09/06/2005US6939568 Hydrated dressing containing metal microbiocide
09/06/2005US6939562 Collagen/polysaccharide bilayer matrix
09/06/2005US6939540 nucleic acid encoding an angiogenic protein is administered to a cell in a region of a bone such that the nucleic acid is expressed to produce the angiogenic protein, whereby bone density or formation is enhanced within the region
09/01/2005WO2005080392A1 Pyrazoloquinolone derivative and use thereof
09/01/2005WO2005080385A1 Indanol derivative
09/01/2005WO2005079788A1 Amino alcohol compound
09/01/2005WO2005079785A1 Remedies for hyperuricemia and/or gout
09/01/2005WO2005079776A1 Method for treatment or prevention of osteoporosis in individuals with high bone turnover
09/01/2005WO2005018627A8 Alpha-aminoamide derivatives useful as anti-inflammatory agents
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050192350 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents
09/01/2005US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor
09/01/2005US20050192317 Novel diamines having a casr modulating activity
09/01/2005US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2
09/01/2005US20050192304 Rho-kinase inhibitors
09/01/2005US20050192260 Pharmaceutical composition
09/01/2005US20050192227 Method for reducing the risk of cancer
09/01/2005US20050192214 Cyclosporine analogue mixtures and their use as immunomodulating agents
09/01/2005US20050191617 Pramyxovirusl vectors encoding antibody and utilization thereof
09/01/2005US20050191354 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005US20050191289 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption
09/01/2005DE102004050703A1 New calcium lactate malate useful as a food additive or for producing pharmaceutical compositions, especially for treating osteoporosis
09/01/2005CA2557539A1 Indanol derivative
09/01/2005CA2557116A1 Method for treatment or prevention of osteoporosis in individuals with high bone turnover
09/01/2005CA2555421A1 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
09/01/2005CA2555406A1 Improved therapy using a combination of raloxifene and alendronate
09/01/2005CA2555236A1 Methods of modulating cytokine activity; related reagents
09/01/2005CA2552433A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568377A1 Cysteine protease inhibitor
08/31/2005EP1568364A1 Osteogenesis promoter containing beta-cryptoxanthin as the active ingredient
08/31/2005EP1567184A1 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
08/31/2005EP1567182A2 Preventing desensitization of receptors
08/31/2005EP1567160A2 Method of treatment of myocardial infarction
08/31/2005EP1567154A2 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
08/31/2005EP1567150A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/31/2005EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen
08/31/2005EP1448246B1 Homogeneously coated device having osteoinductive and osteoconductive properties
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1163204B1 Lipoxin compounds and their use
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP1135140B1 iBANDRONIC ACID FOR THE PROMOTION OF THE OSSEOINTEGRATION OF ENDOPROSTHESES
08/31/2005EP1070048B1 Calcilytic compounds
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0996731B1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
08/31/2005EP0989973B1 Chalcones having antiproliferative activity
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662534A 1, 2, 3, 4, 7, 8-hexahydro-6h-[1, 4]diazepino[6, 7, 1-1j]quinoline derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662529A Thiazole derivatives as phosphodiesterase IV inhibitors
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662280A Method and apparatus for ultrasound treatment of connective tissue
08/31/2005CN1662248A Compositions against inflammatory processes
08/31/2005CN1662245A (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/31/2005CN1662243A Pharmaceutical composition
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662231A Prevention and treatment of functional somatic disorders, including stress-related disorders
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660884A Anthraquinone ramification of rhubarb, preparing method and combination of medication by using the ramification as active ingredient
08/31/2005CN1660861A Medication towards target of bone, synthetic method and application
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660407A Liquid preparation containing penta peptide of thymus and preparing method
08/31/2005CN1660399A Medication for treating arthralgia due to wind-cold dampness and weary muscles and bones
08/31/2005CN1660381A Film coating agent fro treating wound, bone ache caused from wind dampness and preparing method
08/31/2005CN1660379A Combination of medication, preparing method and method of controlling quality
08/31/2005CN1660355A Chinese materia medica preparation for treating wound, rheumatic bone ache and preparing method
08/31/2005CN1660331A Medication for treating wind dampness, rheumatoid disease and preparation method
08/31/2005CN1660330A Medication for treating necrosis of femoral head and preparation method
08/31/2005CN1660238A External remedy for treating hyperosteogeny
08/31/2005CN1660229A Soft capsule for treating rheumatoid desease
08/31/2005CN1660223A Medication for treating trammatic injury and setting a broken bone and preparation method
08/31/2005CN1660204A Ground substance of plaster of Chinese traditional medicine and plaster for external application prepared from the substance
1 ... 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 ... 820